Madam Chair, I would suggest to the member opposite that it is in Canada's best interests that we work with pharmaceutical companies and with researchers to ensure that we are at the cutting edge of research. That is why we have been making these investments, to make sure that Canada is well prepared to take advantage of what comes forward.
In the House of Commons on June 17th, 2020. See this statement in context.